4B05 | Hydrolase | date | Jun 28, 2012 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Preclinical Characterization Of Azd3839, A Novel Clinical Ca Bace1 Inhibitor For The Treatment Of Alzheimer Disease | ||||||||||||||
authors | F.Jeppsson, S.Eketjall, J.Janson, S.Karlstrom, S.Gustavsson, L.L. A.C.Radesater, B.Ploeger, G.Cebers, K.Kolmodin, B.M.Swahn, S.Von T.Bueters, J.Falting | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Beta-Secretase 1 Chain: A Fragment: Residues 43-453 Synonym: Aspartyl Protease 2, Asp2, Beta-Site Amyloid Precu Protein Cleaving Enzyme 1, Beta-Site App Cleaving Enzyme 1, 2, Membrane-Associated Aspartic Protease 2; Ec: 3.4.23.46 Engineered: Yes Mutation: Yes |
Organism_scientific: Homo Sapiens Organism_common: Human Organism_taxid: 9606 Expression_system: Escherichia Coli Expression_system_taxid: 562 Expression_system_vector_type: Plasmid Expression_system_vector: Pet11a | ||||||||||||||
symmetry | Space Group: P 21 21 21 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 1.80 Å | ||||||||||||
ligand | 32D, ACT, NA BindingDB | enzyme | Hydrolase E.C.3.4.23.46 BRENDA | ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Discovery of AZD3839, a potent and selective BACE1 clinical candidate for the treatment of Alzheimers Disease., Jeppsson F, Eketjall S, Janson J, Karlstrom S, Gustavsson S, Olsson LL, Radesater AC, Ploeger B, Cebers G, Kolmodin K, Swahn BM, von Berg S, Bueters T, Falting J, J Biol Chem. 2012 Oct 9. PMID:23048024 |
Data retrieval |
View 4B05 in 3D |
Visual 3D analysis of 4B05 |
Structure-derived information |
Sequence-derived information |
Other resources with information on 4B05 |
Movements, Movies and Images |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |